Janet Hoek, Lindsay Robertson, Jude Ball, Richard Edwards, Anaru Waa
On August 11 2020, the NZ Parliament passed legislation that extends existing regulation of tobacco and herbal smoking products to vaping products (or electronic nicotine delivery systems [ENDS] and heated tobacco products (HTPs]. The new Act represents an important step in managing access to ENDS and HTPs, and regulating how these are marketed. In this blog, we summarise some of the Act’s key provisions before exploring how the regulations, still to be made available for consultation, could further strengthen the Act’s ability to protect young people. We also consider how other countries considering similar legislation could extend the approach taken in NZ.
Janet Hoek, Richard Edwards, Anaru Waa
This year’s World No Tobacco Day (WNTD) focusses on the tobacco industry’s continued targeting of young people, whose addiction to nicotine will help ensure the industry’s on-going profitability. World Smokefree Day’s social media handle #tobaccoexposed reminds us that, despite a new-found interest in ‘unsmoking’ the world, and moving smokers to “reduced harm” products, tobacco companies continue to develop and promote smoked tobacco products that will appeal to young people. In this blog, we explore how tobacco companies have continued to recruit young people to smoked tobacco; we discuss their efforts to infiltrate public health agendas while continuing to innovate with smoked tobacco, and explain why strong policies and industry denormalisation strategies are vital to ensuring young people remain nicotine free.
Lindsay Robertson1,2, Janet Hoek3, Anna Gilmore1, Richard Edwards 3, Anaru Waa3
1 Tobacco Control Research Group, University of Bath, UK; 2 Dept of Preventive and Social Medicine, University of Otago, NZ; 3 Dept of Public Health, University of Otago Wellington, NZ
The public will soon have the opportunity to make submissions on the long-awaited Smokefree Environments and Regulated Products (Vaping) Amendment Bill (‘the Bill’) which will regulate vaping products and alternative nicotine delivery systems. In a previous blog, ASPIRE 2025 researchers summarised the strengths and limitations of the Bill, and concluded that it contained several important measures, yet could do more to protect the health of children, young people and non-nicotine users. This blog – intended as a follow-up article to further promote discussion – summarises emerging evidence of British American Tobacco’s ambitious plans for its nicotine products, and highlights the disjunction between tobacco companies’ profit goals and public health objectives.
Professors Janet Hoek and Richard Edwards, Emeritus Professor Phil Gendall, Jude Ball, Dr Judith McCool, Anaru Waa, Dr Becky Freeman
Recent media reports have presented conflicting evidence on youth vaping in NZ. While some NZ school principals report concerns about increasing vaping on school grounds and confiscating vapes, ASH Year 10 survey data have been interpreted as suggesting few young people who are non-smokers are vaping. How can these apparently contradictory perceptions co-exist? In this blog, we begin by outlining recent findings on electronic nicotine delivery systems (ENDS) and their potential contribution to public health. We then explore possible explanations for why reports and perceptions about youth vaping sometimes differ and offer suggestions about how this behaviour needs to be more effectively monitored.
Dr Lindsay Robertson, Dr Jerram Bateman, Professor Janet Hoek
Members of the public health community hold divergent views on how access to vaping products or electronic nicotine delivery systems (ENDS) products should be arranged. Some believe ENDS should be as widely available as smoked tobacco and argue for liberal access. However, others suggest smoked tobacco should be much less available than is currently the case and propose that only retailers skilled in supporting smoking cessation should sell ENDS. In this blog, we probe concerns about allowing widespread availability of ENDS and related products. We first draw on related research into smoked tobacco products and then discuss findings from our recently published study that questions the wisdom of allowing ENDS to be sold by non-specialist retailers.